Annick Ruffault

2.1k total citations
46 papers, 1.3k citations indexed

About

Annick Ruffault is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Annick Ruffault has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Virology, 29 papers in Infectious Diseases and 14 papers in Epidemiology. Recurrent topics in Annick Ruffault's work include HIV Research and Treatment (31 papers), HIV/AIDS drug development and treatment (26 papers) and HIV/AIDS Research and Interventions (19 papers). Annick Ruffault is often cited by papers focused on HIV Research and Treatment (31 papers), HIV/AIDS drug development and treatment (26 papers) and HIV/AIDS Research and Interventions (19 papers). Annick Ruffault collaborates with scholars based in France, Switzerland and United States. Annick Ruffault's co-authors include Bernard Jégou, Diane Descamps, Bernard Masquelier, Jacques Izopet, Françoise Brun‐Vézinet, Nathalie Dejucq‐Rainsford, Dominique Costagliola, Vincent Cálvez, Catherine Tamalet and Jean‐Christophe Plantier and has published in prestigious journals such as The Lancet, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Annick Ruffault

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annick Ruffault France 25 873 830 280 162 136 46 1.3k
Snježana Židovec Lepej Croatia 17 390 0.4× 193 0.2× 378 1.4× 121 0.7× 107 0.8× 101 947
Erika Benko Canada 21 584 0.7× 931 1.1× 296 1.1× 831 5.1× 53 0.4× 41 1.6k
Céline Montavon Switzerland 20 729 0.8× 718 0.9× 185 0.7× 91 0.6× 31 0.2× 49 1.1k
Giulia Matusali Italy 19 743 0.9× 269 0.3× 289 1.0× 315 1.9× 10 0.1× 72 1.4k
Michele Till United States 12 320 0.4× 276 0.3× 242 0.9× 113 0.7× 65 0.5× 18 729
J Puel France 28 998 1.1× 828 1.0× 971 3.5× 128 0.8× 907 6.7× 61 2.1k
Anna Le Tortorec France 12 414 0.5× 560 0.7× 368 1.3× 344 2.1× 25 0.2× 22 1.1k
Steffanie Sabbaj United States 21 530 0.6× 880 1.1× 480 1.7× 1.1k 7.0× 38 0.3× 46 1.9k
Theresa Flynn United States 12 509 0.6× 1.1k 1.3× 412 1.5× 807 5.0× 111 0.8× 15 1.6k
Megan Mefford United States 14 522 0.6× 928 1.1× 265 0.9× 641 4.0× 43 0.3× 14 1.6k

Countries citing papers authored by Annick Ruffault

Since Specialization
Citations

This map shows the geographic impact of Annick Ruffault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annick Ruffault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annick Ruffault more than expected).

Fields of papers citing papers by Annick Ruffault

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annick Ruffault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annick Ruffault. The network helps show where Annick Ruffault may publish in the future.

Co-authorship network of co-authors of Annick Ruffault

This figure shows the co-authorship network connecting the top 25 collaborators of Annick Ruffault. A scholar is included among the top collaborators of Annick Ruffault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annick Ruffault. Annick Ruffault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deléage, Claire, et al.. (2011). Human Immunodeficiency Virus Infects Human Seminal Vesicles in Vitro and in Vivo. American Journal Of Pathology. 179(5). 2397–2408. 45 indexed citations
2.
Bentué‐Ferrer, Danièle, C. Arvieux, Olivier Tribut, Annick Ruffault, & Éric Bellissant. (2009). Clinical pharmacology, efficacy and safety of atazanavir: a review. Expert Opinion on Drug Metabolism & Toxicology. 5(11). 1455–1468. 25 indexed citations
3.
Tortorec, Anna Le, Hélène Denis, J.J. Patard, et al.. (2008). Antiviral responses of human Leydig cells to mumps virus infection or poly I:C stimulation. Human Reproduction. 23(9). 2095–2103. 44 indexed citations
4.
Masquelier, Bernard, Diane Descamps, Laurence Bocket, et al.. (2008). Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir. Journal of Antimicrobial Chemotherapy. 61(6). 1362–1368. 13 indexed citations
5.
Tortorec, Anna Le, Anne-Pascale Satié, Hélène Denis, et al.. (2008). Human prostate supports more efficient replication of HIV-1 R5 than X4 strains ex vivo. Retrovirology. 5(1). 119–119. 26 indexed citations
6.
Costagliola, Dominique, Diane Descamps, Lambert Assoumou, et al.. (2007). Prevalence of HIV-1 Drug Resistance in Treated Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(1). 12–18. 40 indexed citations
7.
Maillard, Anne, Jean-Marc Chapplain, Olivier Tribut, et al.. (2007). The use of drug resistance algorithms and genotypic inhibitory quotient in prediction of lopinavir–ritonavir treatment response in human immunodeficiency virus type 1 protease inhibitor-experienced patients. Journal of Clinical Virology. 38(2). 131–138. 13 indexed citations
8.
Camus, Claire, et al.. (2007). Multiple Organ Failure during Primary HIV Infection. Clinical Infectious Diseases. 44(3). e28–e29. 19 indexed citations
9.
Satié, Anne-Pascale, Annick Ruffault, Anna Le Tortorec, et al.. (2006). Susceptibility of Human Testis to Human Immunodeficiency Virus-1 Infection in Situ and in Vitro. American Journal Of Pathology. 169(6). 2094–2103. 54 indexed citations
10.
Chaix, Marie‐Laure, Diane Descamps, M Harzic, et al.. (2003). Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. AIDS. 17(18). 2635–2643. 89 indexed citations
11.
12.
Arvieux, C., Pierre Tattevin, Faouzi Souala, et al.. (2002). Salvage therapy with amprenavir and ritonavir: Prospective study in 17 heavily pretreated patients. HIV Clinical Trials. 3(2). 125–132. 11 indexed citations
13.
Descamps, Diane, Vincent Cálvez, Jacques Izopet, et al.. (2001). Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study. AIDS. 15(14). 1777–1782. 30 indexed citations
14.
Burgard, Marianne, Jacques Izopet, Catherine Tamalet, et al.. (2000). HIV RNA and HIV DNA in Peripheral Blood Mononuclear Cells Are Consistent Markers for Estimating Viral Load in Patients Undergoing Long-Term Potent Treatment. AIDS Research and Human Retroviruses. 16(18). 1939–1947. 41 indexed citations
15.
Michelet, C., Éric Bellissant, Annick Ruffault, et al.. (1999). Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine. Clinical Pharmacology & Therapeutics. 65(6). 661–671. 6 indexed citations
16.
Allain, H., Danièle Bentué‐Ferrer, Stéphane Schück, & Annick Ruffault. (1999). [Beta interferon in multiple sclerosis: pharmacological differences].. PubMed. 155 Suppl 2. S24–30. 1 indexed citations
17.
Dubois, Véronique, Hélène Moret, Marie‐Edith Lafon, et al.. (1998). Prevalence of JC Virus Viraemia in HIV-Infected Patients with or Without Neurological Disorders: A Prospective Study. Journal of NeuroVirology. 4(5). 539–544. 27 indexed citations
18.
Colimon, R., S. Minjolle, Patrice André, et al.. (1996). New types of primers (stair primers) for PCR amplification of the variable V3 region of the human immunodeficiency virus. Journal of Virological Methods. 58(1-2). 7–19. 8 indexed citations
19.
Ruffault, Annick, et al.. (1988). Interferon Production in Severe Hemophiliacs with and without HIV Antibodies. Journal of Interferon Research. 8(1). 89–94. 7 indexed citations
20.
André, Patrice, et al.. (1988). Evaluation of herpes simplex virus susceptibility to acyclovir using an enzyme-linked immunosorbent assay. Annales de l Institut Pasteur Virologie. 139(2). 185–195. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Snježana Židovec Lepej Breakdown of academic impact, for papers by Erika Benko Breakdown of academic impact, for papers by Céline Montavon Breakdown of academic impact, for papers by Giulia Matusali Breakdown of academic impact, for papers by Michele Till Breakdown of academic impact, for papers by J Puel Breakdown of academic impact, for papers by Anna Le Tortorec Breakdown of academic impact, for papers by Steffanie Sabbaj Breakdown of academic impact, for papers by Theresa Flynn Breakdown of academic impact, for papers by Megan Mefford
Rankless by CCL
2026